Amato Giaccia
Professor of Radiation Oncology
- Jack, Lulu & Sam Willson Professor in Cancer Biology
Research Summary
My research program is focused on translating basic science findings on the role of hypoxia in tumour progression and resistance to therapy to pre-clinical models of cancer that I ultimately hopes to take into the clinic. My overarching hypothesis is that hypoxia not only makes tumour cells resistant to radiotherapy, chemotherapy and in some cases targeted therapy, but also increases their invasiveness and metastatic potential by inducing a select group of genes involved in tissue remodeling.
Biography
Until moving to Oxford, Amato was “Jack, Lulu and Sam Willson Professor in Cancer Biology” in the Stanford University School of Medicine, Professor of Radiation Oncology, Associate Chair for Research & Director of the Division of Radiation & Cancer Biology in the Department of Radiation Oncology at Stanford University, California. He was the Director of Basic Science at the Stanford Cancer Institute and lead the Radiation Biology Program in Stanford’s Cancer Center, and was Director of the Cancer Biology Interdisciplinary Graduate Program.
He was awarded an American Cancer Society Junior Faculty Research Award and the Michael Fry Award from the Radiation Research Society for his outstanding contributions on understanding the molecular mechanisms of resistance promoted by the tumor microenvironment. Additionally, he was the recipient of the 2013 ASTRO Gold Medal. In 2015, he was awarded an NIH R35 Outstanding Investigator Award and was inducted into the National Academy of Medicine.
He co-authored the sixth, seventh & eighth editions of the textbook, “Radiation Biology for the Radiologist,” with Professor Eric Hall from Columbia.
Key publications
-
Journal article
Olcina MM. et al, (2018), Cell Rep, 25, 3721 - 3732.e6
-
Journal article
Chen X. et al, (2018), Nat Commun, 9
-
Journal article
Benej M. et al, (2018), Proc Natl Acad Sci U S A, 115, 10756 - 10761
-
Journal article
Rafat M. et al, (2018), Cancer Res, 78, 4241 - 4252
-
Journal article
LaGory EL. and Giaccia AJ., (2017), Nat Med, 23, 1251 - 1252
-
Journal article
Chiou S-H. et al, (2017), Cancer Discov, 7, 1184 - 1199
-
Journal article
Rankin EB. et al, (2016), Trends Cancer, 2, 295 - 304
-
Journal article
Peinado H. et al, (2017), Nat Rev Cancer, 17, 302 - 317
-
Journal article
Aguilera TA. and Giaccia AJ., (2017), Clin Cancer Res, 23, 2928 - 2933
-
Journal article
Castellini L. et al, (2017), Nucleic Acids Res, 45, 3674 - 3692
-
Journal article
Aguilera TA. et al, (2016), Nat Commun, 7
-
Journal article
Kariolis MS. et al, (2017), J Clin Invest, 127, 183 - 198
-
Journal article
Johnson RW. et al, (2016), Nat Cell Biol, 18, 1078 - 1089
-
Journal article
Olcina MM. and Giaccia AJ., (2016), J Clin Invest, 126, 3708 - 3715
-
Journal article
Rankin EB. and Giaccia AJ., (2016), Science, 352, 175 - 180